These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

652 related items for PubMed ID: 19357796

  • 1. Advanced magnetic resonance imaging metrics: implications for multiple sclerosis clinical trials.
    Zivadinov R.
    Methods Find Exp Clin Pharmacol; 2009; 31(1):29-40. PubMed ID: 19357796
    [Abstract] [Full Text] [Related]

  • 2. Magnetic resonance imaging monitoring of multiple sclerosis lesion evolution.
    Inglese M, Grossman RI, Filippi M.
    J Neuroimaging; 2005; 15(4 Suppl):22S-29S. PubMed ID: 16385016
    [Abstract] [Full Text] [Related]

  • 3. T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis.
    Neema M, Stankiewicz J, Arora A, Dandamudi VS, Batt CE, Guss ZD, Al-Sabbagh A, Bakshi R.
    J Neuroimaging; 2007 Apr; 17 Suppl 1():16S-21S. PubMed ID: 17425729
    [Abstract] [Full Text] [Related]

  • 4. Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives.
    Bar-Zohar D, Agosta F, Goldstaub D, Filippi M.
    Mult Scler; 2008 Jul; 14(6):719-27. PubMed ID: 18424478
    [Abstract] [Full Text] [Related]

  • 5. MRI as an outcome in multiple sclerosis clinical trials.
    Daumer M, Neuhaus A, Morrissey S, Hintzen R, Ebers GC.
    Neurology; 2009 Feb 24; 72(8):705-11. PubMed ID: 19073945
    [Abstract] [Full Text] [Related]

  • 6. [Magnetic resonance in the diagnosis and treatment of multiple sclerosis].
    Rovira Cañellas A.
    Neurologia; 2000 Feb 24; 15(7):288-302. PubMed ID: 11075577
    [Abstract] [Full Text] [Related]

  • 7. Clinical-magnetic resonance imaging correlations in multiple sclerosis.
    Zivadinov R, Leist TP.
    J Neuroimaging; 2005 Feb 24; 15(4 Suppl):10S-21S. PubMed ID: 16385015
    [Abstract] [Full Text] [Related]

  • 8. Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment?
    Goodin DS.
    Ann Neurol; 2006 Apr 24; 59(4):597-605. PubMed ID: 16566022
    [Abstract] [Full Text] [Related]

  • 9. Black holes in multiple sclerosis: definition, evolution, and clinical correlations.
    Sahraian MA, Radue EW, Haller S, Kappos L.
    Acta Neurol Scand; 2010 Jul 24; 122(1):1-8. PubMed ID: 20003089
    [Abstract] [Full Text] [Related]

  • 10. Magnetic resonance imaging of multiple sclerosis lesions. Measuring outcome in treatment trials.
    Simon JH.
    West J Med; 1996 Jun 24; 164(6):502-9. PubMed ID: 8764625
    [Abstract] [Full Text] [Related]

  • 11. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].
    Zivadinov R, Sepcić J.
    Lijec Vjesn; 2006 Jun 24; 128(9-10):295-308. PubMed ID: 17128669
    [Abstract] [Full Text] [Related]

  • 12. Magnetic resonance imaging and treatment effects of multiple sclerosis therapeutics.
    Leist TP, Marks S.
    Neurology; 2010 Jan 05; 74 Suppl 1():S54-61. PubMed ID: 20038764
    [Abstract] [Full Text] [Related]

  • 13. Magnetic resonance imaging advances in multiple sclerosis.
    Bakshi R.
    J Neuroimaging; 2005 Jan 05; 15(4 Suppl):5S-9S. PubMed ID: 16385014
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Functional magnetic resonance imaging and multiple sclerosis: the evidence for neuronal plasticity.
    Buckle GJ.
    J Neuroimaging; 2005 Jan 05; 15(4 Suppl):82S-93S. PubMed ID: 16385021
    [Abstract] [Full Text] [Related]

  • 16. MRI in multiple sclerosis.
    Simon JH.
    Phys Med Rehabil Clin N Am; 2005 May 05; 16(2):383-409, viii. PubMed ID: 15893678
    [Abstract] [Full Text] [Related]

  • 17. Magnetic resonance imaging in multiple sclerosis.
    Napoli SQ, Bakshi R.
    Rev Neurol Dis; 2005 May 05; 2(3):109-16. PubMed ID: 16400309
    [Abstract] [Full Text] [Related]

  • 18. Clinical and imaging metrics for monitoring disease progression in patients with multiple sclerosis.
    Bagnato F, Ohayon JM, Ehrmantraut M, Chiu AW, Riva M, Ikonomidou VN.
    Expert Rev Neurother; 2006 Apr 05; 6(4):599-612. PubMed ID: 16623658
    [Abstract] [Full Text] [Related]

  • 19. MRI to monitor treatment efficacy in multiple sclerosis.
    Fazekas F, Soelberg-Sorensen P, Comi G, Filippi M.
    J Neuroimaging; 2007 Apr 05; 17 Suppl 1():50S-55S. PubMed ID: 17425736
    [Abstract] [Full Text] [Related]

  • 20. Measuring brain atrophy in multiple sclerosis.
    De Stefano N, Battaglini M, Smith SM.
    J Neuroimaging; 2007 Apr 05; 17 Suppl 1():10S-15S. PubMed ID: 17425728
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.